Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aptevo Therapeutics Inc (NQ: APVO ) 0.1681 -0.0117 (-6.51%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 601,445 Open 0.1778 Bid (Size) 0.1655 (5) Ask (Size) 0.1765 (25) Prev. Close 0.1798 Today's Range 0.1621 - 0.1797 52wk Range 0.1250 - 10.80 Shares Outstanding 11,523,716 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules September 18, 2024 Via ACCESSWIRE Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket September 17, 2024 Via Benzinga Performance YTD -5.56% -5.56% 1 Month -51.63% -51.63% 3 Month -43.59% -43.59% 6 Month -95.78% -95.78% 1 Year -50.72% -50.72% More News Read More Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules September 16, 2024 Via ACCESSWIRE Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated August 13, 2024 Via ACCESSWIRE Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA May 14, 2024 Via ACCESSWIRE Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study September 16, 2024 Via ACCESSWIRE Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024 September 13, 2024 Via ACCESSWIRE APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024 August 08, 2024 Via InvestorPlace Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update August 08, 2024 Via ACCESSWIRE Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 18, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday July 18, 2024 Via InvestorPlace Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket July 18, 2024 Via Benzinga Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket July 17, 2024 Via Benzinga Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 17, 2024 Via Benzinga Aptevo Therapeutics Announces Closing of $2.75 Million Offering July 01, 2024 Via ACCESSWIRE Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules June 28, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Monday's Pre-Market Session June 17, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 17, 2024 Via InvestorPlace Aptevo Participating in the BIO International Convention June 03, 2024 Via ACCESSWIRE APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024 May 08, 2024 Via InvestorPlace Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update May 08, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Friday's After-Market Session May 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 02, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 02, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
